Silicon Valley billionaires are investing in cellular reprogramming research aimed at extending human longevity, Business Insider reported. Jeff Bezos and Sam Altman are backing efforts to deliver "instructions" to cells to revert them to a youthful state. Early trials on patients have begun, with no serious side effects reported and improved vision observed in two cases.